“CBD administration did not affect any of the dependent variables measured compared to the placebo group,” investigators concluded. The post Clinical Trial: CBD Dosing Not Associated With Cognitive Impairment appeared first on NORML.
Meta-Analysis: Cannabis May Be “Beneficial in Inducing Clinical Remission” in Patients With Crohn’s Disease
“Individuals receiving cannabis treatment exhibited substantially higher rates of clinical remission at eight weeks compared to those in the control group,” researchers concluded. The post Meta-Analysis: Cannabis May Be “Beneficial in Inducing Clinical Remission” in […]
IIPR reaches deal with PharmaCann to resolve lease default
Innovative Industrial Properties (NYSE: IIPR) said it reached an agreement with multistate operator PharmaCann to resolve defaults on leases for 11 properties, as the cannabis real estate investment trust faces more scrutiny over its tenant disclosures. The deal, which became effective Tuesday, includes rent reductions and property transitions in key …
Case Report: Cannabis Oil Provides Symptomatic Improvements in Patient With Parkinson’s Disease
The patient’s symptoms continued to improve throughout the trial period, resulting in a reduction in his use of prescription medicines. The post Case Report: Cannabis Oil Provides Symptomatic Improvements in Patient With Parkinson’s Disease appeared […]